Month: November 2023

The efficacy and safety of anti-Aβ agents for delaying cognitive decline in Alzheimer’s disease: a meta-analysis

BackgroundThis meta-analysis evaluates the efficacy and safety of amyloid-β (Aβ) targeted therapies for delaying cognitive deterioration in Alzheimer’s disease (AD).MethodsPubMed, EMBASE, the Cochrane Library, and ClinicalTrials.gov were systematically searched to identify relevant studies published before January 18, 2023.ResultsWe pooled 33,689 participants from 42 studies. The meta-analysis showed no difference between anti-Aβ drugs and placebo in […]

Published on November 6, 2023

One in 7 Americans Has Had Long COVID

As many as 1 in 3 people who fall ill with COVID-19 will develop long COVID, with symptoms that can persist for months or years, a new study estimates. Nearly half of participants (47%) in a large-scale U.S. Census Bureau survey said they had been infected with COVID-19 by… Read Full Article (External Site) Dr. […]

Published on November 6, 2023

More Fruit Pouches Recalled Due to Lead Contamination

Federal health officials are expanding an investigation into potentially lead-tainted pouches of apple cinnamon fruit puree marketed for children amid reports of more illnesses and additional product recalls. The U.S. Food and Drug Administration said Friday it has received… Read Full Article (External Site) Dr. David LowemannDr. David Lowemann, M.Sc, Ph.D., is a co-founder of […]

Published on November 6, 2023